Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Comparative study of the safety, efficacy, and practice patterns of Monoclonal antibodies (MAbs) in pediatric renal transplantation (PRT)

Go back to Resources

Comparative study of the safety, efficacy, and practice patterns of Monoclonal antibodies (MAbs) in pediatric renal transplantation (PRT)

Authors:

Location:

Go back to Resources

Clinical trials referral resource. Clinical trials and NCI resources for cancer in HIV+ patients

Go back to Resources

Clinical trials referral resource. Clinical trials and NCI resources for cancer in HIV+ patients

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Calculated Creatinine Clearance (CCC) as the Most Promising Candidate Surrogate End Point for Clinical Trials

Go back to Resources

Calculated Creatinine Clearance (CCC) as the Most Promising Candidate Surrogate End Point for Clinical Trials

Authors:

Location:

Go back to Resources

Adverse clinical outcomes associated with short stature at dialysis initiation: a report of the North American Pediatric Renal Transplant Cooperative Study

Go back to Resources

Adverse clinical outcomes associated with short stature at dialysis initiation: a report of the North American Pediatric Renal Transplant Cooperative Study

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Ability of minority patients to find donors from an ethnically diverse cord blood bank

Go back to Resources

Ability of minority patients to find donors from an ethnically diverse cord blood bank

Authors:

Location:

Go back to Resources

4 Year Daclizumab Therapy for Sight Threatening Uveitis

Go back to Resources

4 Year Daclizumab Therapy for Sight Threatening Uveitis

Authors:

Location:

Go back to Resources

Umbilical cord blood transplantation in adults: results of a prospective, multi-institutional, NHLBI sponsored trial

Go back to Resources

Umbilical cord blood transplantation in adults: results of a prospective, multi-institutional, NHLBI sponsored trial

Authors:

Location:

Go back to Resources

The treatment of JRA-associated uveitis with Etanercept

Go back to Resources

The treatment of JRA-associated uveitis with Etanercept

Authors:

Location:

Go back to Resources

The safety and efficacy of chicken type II collagen on uveitis associated with juvenile rheumatoid arthritis

Go back to Resources

The safety and efficacy of chicken type II collagen on uveitis associated with juvenile rheumatoid arthritis

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

The Results of the Age-Related Eye Disease Study (AREDS)

Go back to Resources

The Results of the Age-Related Eye Disease Study (AREDS)

Authors:

Location:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 134
  • Page 135
  • Page 136
  • Page 137
  • Current page 138
  • Page 139
  • Page 140
  • Page 141
  • Page 142
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • ISO Certification